Biocon

Biocon Limited is India’s largest and most prominent biopharmaceutical company, specializing in the development and manufacture of high-quality, affordable medicines for chronic conditions. Headquartered in Bangalore and founded by Kiran Mazumdar-Shaw in 1978, the company has evolved from an enzyme manufacturer into a fully integrated global biopha... rma leader. Biocon operates through four key strategic business units: Generics (APIs and formulations), Biosimilars (via Biocon Biologics), Novel Biologics, and Research Services (via its subsidiary, Syngene). The company is a global leader in biosimilar insulins and monoclonal antibodies, particularly in oncology, diabetes, and immunology. As of 2026, Biocon remains at the forefront of the "GLP-1" peptide market and continues to expand its reach across 120+ countries, driven by a mission to provide equitable access to life-saving healthcare for a billion people.Read More